Publicly subsidised smoking cessation medicines in times of COVID‐19 in Australia: An interrupted time series analysis

INTRODUCTION: In Australia, the available published literature demonstrated a spike in dispensed prescription medicines after the onset of the COVID‐19 pandemic that subsequently returned to expected levels. Smoking cessation medicines may not follow this pattern because quit attempts are influenced...

Descripción completa

Detalles Bibliográficos
Autores principales: Baliunas, Dolly, Gartner, Coral, Hollingworth, Samantha A., Sullivan, Clair, Comans, Tracy, Pole, Jason D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087959/
https://www.ncbi.nlm.nih.gov/pubmed/36173196
http://dx.doi.org/10.1111/dar.13557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087959/
https://www.ncbi.nlm.nih.gov/pubmed/36173196
http://dx.doi.org/10.1111/dar.13557

Ejemplares similares